Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation study.

Omar Elkayal Beatrijs Mertens Joost Wauters Yves Debaveye Bart J A Rijnders Paul E Verweij Roger J M Brüggemann Isabel Spriet Erwin Dreesen

Published in: The Journal of antimicrobial chemotherapy (2024)

We have defined a convenient, optimized IV posaconazole dosing regimen that was predicted to attain the treatment target in critically ill patients with invasive aspergillosis.

Keyphrases

pulmonary hypertension
smoking cessation